Myocardial Tissue Velocity Imaging: Its Role in evaluation of Diastolic Dysfunction

Similar documents
Note: The left and right sides of the heart must pump exactly the same volume of blood when averaged over a period of time

Section Four: Pulmonary Artery Waveform Interpretation

Vs. K. Farsalinos, D. Tsiapras, S. Kyrzopoulos, M. Savvopoulou, E. Avramidou, D. Vassilopoulou, V. Voudris

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography

Normal & Abnormal Intracardiac. Lancashire & South Cumbria Cardiac Network

The P Wave: Indicator of Atrial Enlargement

Congestive heart failure (CHF) is a. Diastolic Heart Failure. By Michel D Astous, MD, FRCPC

Disclosure. All the authors have no conflict of interest to disclose in this study.

Fellow TEE Review Workshop Hemodynamic Calculations Director, Intraoperative TEE Program. Johns Hopkins School of Medicine

Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity

Normal Intracardiac Pressures. Lancashire & South Cumbria Cardiac Network

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

Electrocardiography Review and the Normal EKG Response to Exercise

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

INHERIT. The Lancet Diabetes & Endocrinology In press

Dysfunction of aortic valve prostheses

5. Management of rheumatic heart disease

GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS

How should we treat atrial fibrillation in heart failure

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery

Chapter 20: The Cardiovascular System: The Heart

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Diagnostic and Therapeutic Procedures

Exchange solutes and water with cells of the body

Sam Esfandiari. Copyright by Sam Esfandiari (2012)

Anaesthesia and Heart Failure

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Mitral valve repair current Status and the modern Sternotomy

Resuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto

Workshop B: Essentials of Neonatal Cardiology and CHD Anthony C. Chang, MD, MBA, MPH CARDIAC INTENSIVE CARE

Anatomi & Fysiologi The cardiovascular system (chapter 20) The circulation system transports; What the heart can do;

12-Lead EKG Interpretation. Judith M. Haluka BS, RCIS, EMT-P

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Magnetic Resonance Quantitative Analysis. MRV MR Flow. Reliable analysis of heart and peripheral arteries in the clinical workflow

Updated Cardiac Resynchronization Therapy Guidelines

Pregnancy causes dramatic, usually reversible, changes in

Quantification of Aortic Stenosis based on the Morphology of Doppler Ultrasound Signals using Image Processing techniques

Equine Cardiovascular Disease

Normal ranges of left ventricular global longitudinal strain: A meta-analysis of 2484 subjects

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

Original Article CONCLUSION OBJECTIVE KEY WORDS METHODS RESULTS

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code )

Introduction to CV Pathophysiology. Introduction to Cardiovascular Pathophysiology

1 Congestive Heart Failure & its Pharmacological Management

Heart Sounds & Murmurs

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION

HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise

EAE TEACHING COURSE Aorta and aortic valve 2012

Imaging. Impact of Progression of Diastolic Dysfunction on Mortality in Patients With Normal Ejection Fraction

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Circulatory System Review

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

How To Understand What You Know

The pulse Tamás Fenyvesi

Recommendations for Evaluation of the Severity of Native Valvular Regurgitation with Two-dimensional and Doppler Echocardiography

Real-Time 3-Dimensional Transesophageal Echocardiography in the Evaluation of Post-Operative Mitral Annuloplasty Ring and Prosthetic Valve Dehiscence

HISTORY. Questions: 1. What diagnosis is suggested by this history? 2. How do you explain her symptoms during pregnancy?

Diastolic Heart Failure: Restrictive Cardiomyopathy, Constrictive Pericarditis, and Cardiac Tamponade: Clinical and Echocardiographic Evaluation

Listen to your heart: Good Cardiovascular Health for Life

Nursing Care and Considerations for Patients with Atrial Fibrillation. Kris Kinghorn RN, MSN, ANP-BC

Heart valve repair and replacement

Press conference: Rheumatic Heart Disease a forgotten but devastating disease

Mr GH: Pericardial Window. Anaesthetic Management of Cardiac Tamponade

ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA

Heart failure affects approximately

THE HEART Dr. Ali Ebneshahidi

Pulmonary Hypertension in Sickle Cell Disease. Jorge Ramos Hematology Fellows Conference June 28, 2013

Blood Flow Hemodynamics, Cardiac Mechanics, and Doppler Echocardiography

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

How do you decide on rate versus rhythm control?

Echo Assessment of Diastolic Function

Atrial Fibrillation An update on diagnosis and management

Non-Invasive Risk Predictors in (Children with) Pulmonary Hypertension

New insights in the assessment of right ventricular function: an echocardiographic study. Avin Calcutteea

Vtial sign #1: PULSE. Vital Signs: Assessment and Interpretation. Factors that influence pulse rate: Importance of Vital Signs

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

Atrial Fibrillation The Basics

Auscultation of the Heart

HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs)

Traumatic Cardiac Tamponade. Shane KF Seal 19 November 2003 POS

Doppler. Doppler. Doppler shift. Doppler Frequency. Doppler shift. Doppler shift. Chapter 19

RACE I Rapid Assessment by Cardiac Echo. Intensive Care Training Program Radboud University Medical Centre NIjmegen

Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April Reference: NHSCB/A09/PS/b

The new Heart Failure pathway

Section 8: Clinical Exercise Testing. a maximal GXT?

How do you decide on rate versus rhythm control?

The heart then repolarises (or refills) in time for the next stimulus and contraction.

Objectives. The ECG in Pulmonary and Congenital Heart Disease. Lead II P-Wave Amplitude during COPD Exacerbation and after Treatment (50 pts.

May 1 6, 2016 Loews Atlanta Hotel Atlanta, GA PRELIMINARY PROGRAM AT A GLANCE

Name: Age: Resting BP: Wt. kg: Est. HR max : 85%HR max : Resting HR:

Universitätsklinik für Kardiologie. Test. Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie 1

Atrial Fibrillation (AF) March, 2013

Detection of Heart Diseases by Mathematical Artificial Intelligence Algorithm Using Phonocardiogram Signals

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013

Dynamic Auscultation of Heart Sounds and Murmurs. Acknowledgement. Disclosures Real or Potential Conflicts of Interest

ATRIAL FIBRILLATION: Scope of the Problem. October 2015

INTRODUCTION TO EECP THERAPY

Transcription:

Myocardial Tissue Velocity Imaging: Its Role in evaluation of Diastolic Dysfunction Tarun Pandey MD, DNB, FRCR Assistant Professor, University of Arkansas for Medical Sciences, Little Rock, AR.

Outline Background on Diastolic Dysfunction & Diastolic Heart Failure. Review of Parameters used for evaluation of Diastolic Dysfunction & Diastolic Heart Failure. Morphological Parameters Functional Parameters o Transmitral flow o Pulmonary Vein flow o Myocardial tissue velocity imaging Definition What are the factors that affect it? How is it different than other functional parameters? How is it measured using Echo and CMR? What is the clinical utility of this parameter? Is there data to show its clinical value?

Why bother about Diastolic function & DHF? Diastolic Heart failure [DHF] is a real clinical entity. Diagnostic Criteria: signs and symptoms of Heart Failure; normal or mildly abnormal systolic LV function; and evidence of LV diastolic dysfunction. Heart failure with preserved ejection fraction represents approximately 40% 50% of all cases of heart failure, and its prevalence is increasing. Owan TE et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. NEJM 2006;355(3):251 259. Maeder MT, Kaye DM. Heart failure with normal left ventricular ejection fraction. JACC 2009;53(11):905 918.

Why bother about Diastolic function & DHF? Diagnosis is difficult Diastology is a complex subject No single parameter is good enough short of invasive measurements Treatment is difficult No effective cure Frequently irreversible Mortality and morbidity is similar to systolic heart failure.

What are the ways we can diagnose Diastolic Dysfunction or DHF? Invasive Non Invasive

What are the ways we can diagnose Diastolic Dysfunction or DHF Invasive Elevated LV end diastolic pressure (>16mmHg). Elevated mean PCWP >12mmHg. Increased time constant of LV relaxation τ >48ms. Increase in the constant for LV chamber stiffness b >0.27.

What are the ways we can diagnose Diastolic Dysfunction or DHF Invasive Non Invasive Clinical [Signs of HF, EKG (A fib.), BNP] Morphological Functional Flow Transmitral Flow (TMF) Pulmonary vein flow Left ventricular filling Tissue motion

Can we use MRI to study these parameters?

Morphological Parameter: LA Vol LA volume: Morphological expression of LV diastolic dysfunction Biomarker of the chronicity of diastolic dysfunction. Provides significant insight into an individual s risk of the development of adverse cardiovascular events, including MI, stroke, AF and heart failure*. LA volume is graded relative to risk as mild (28 33ml/m 2 ), moderate (34 39ml/m 2 ) or severe (>40ml/m 2 ) *Takemoto Y, et al., Am J Cardiol, 2005;96(6):832 6.

Morphological parameter: How to calculate LA Vol. on CMR? Biplane Area-Length method used for MR evaluation of Left atrial volume on Cine-true FISP 4-CH and 2-CH views LA Volume = (0.85 x A1 x A2)/ L L= LA length A1= LA area in 2-CH view A2= LA area in 4-CH view

Left Atrial Volume Strength Provides morphologic and physiologic evidence for chronic elevation in filling pressure Severity scale based on clinical outcomes** Weakness May be enlarged in other medical conditions including chronic anemia, athletic heart, chronic valvular disease without increase in LV filling pressure. **Tsang TS, et al., Am J Cardiol, 2002;90(12):1284 9.

How can we use MRI to study functional parameters?

Functional Parameter #1: Transmitral Flow Ejection The cardiac cycle consists of four phases shown in the diagram. LV Pressure IVRT SV IVRT: Isovolumetric relaxation IVCT: Isovolumetric contraction ESV: End Systolic Volume EDV: End Diastolic Volume IVCT Notice the pressure-vol. changes during the cycle, in particular during IVRT and ventricular filling. Filling ESV EDV LV volume

Functional Parameters: Transmitral Flow Diastole, in turn, is divided into four stages: 1. Isovolumetric relaxation 2. Early rapid diastolic filling 3. Diastasis 4. Late diastolic atrial filling Notice that the Transmitral Pressure Gradient (TMPG) is the actual determinant of LV filling. TMPG is influenced by: LV relaxation LV compliance (which affects LA pressures) Pressure Distance LV LA IVRT Aortic Closure Opening Mitral Closure Opening Aortic Closure Opening Mitral Closure Opening Time Ao IVCT

Functional Parameter: Transmitral Flow Mitral inflow is quantified by measuring the E-wave, the A-wave, the E/A ratio and the Deceleration Time (DT): E-wave represents early mitral inflow velocity and is influenced by the relative pressures between the LA and LV; A-wave represents the atrial contractile component of mitral filling and is influenced by LV compliance and LA contractility; and DT represents the interval from E-wave peak to a point of intersection of the deceleration of flow with the baseline. It correlates with time of pressure equalization between the LA and LV. As the early LA and LV filling pressures either evolve toward or away from equivalence, the DT either shortens or lengthens, respectively.

Mitral Valve evaluation: How to obtain Mitral Flow and Velocity Curves on CMR?

Mitral TMF evaluation: How to calculate EA ratio, DT and E-wave upslope from the flow / velocity curves? E-wave Peak A-wave Peak E-wave upslope DT

Mitral valvular flow: E/A ratio, E-wave upslope and DT Strength Can be obtained in all patients Provides diagnostic and prognostic information Been validated to be consistent across modalities. Weakness Highly preload dependant Difficult to obtain without good EKG tracing Problematic at high heart rates, atrial fibrillation, heart block.

Functional Parameter # 2: Pulmonary vein flow The normal pulmonary vein flow pattern reflects changes in LV compliance. It consists of the: S-wave, occurring during LV systole, and dependent on atrial relaxation and mitral annulus motion; D-wave, occurring during LV diastole and reflecting LV filling; and A-wave, which is below the baseline as opposed to the S and D waves, occurs during atrial contraction.

Pulmonary vein evaluation: How to obtain pulmonary vein flow curve on CMR? Phase contrast cine MR image through the pulmonary vein

Pulmonary vein evaluation: How to calculate pulmonary vein SD ratio, A-wave amplitude & duration on CMR? Systolic Peak Diastolic Peak A-wave Duration A-wave Amplitude

Pulmonary Vein Flow Strength Weakness Complements mitral flow parameters especially when fusion of E and A wave. In differentiating normal vs. pseudonormal pattern. The relationship of PV-A reversal (PVAR) duration to mitral A duration is the only marker specific for elevation in LVEDP Can be difficult to obtain especially in a patient who cannot breath hold (especially on Echo). Like mitral inflow, this parameter is dependent on the myocardial rhythm.

Interplay of Functional Parameters: Transmitral & Pulmonary vein flow in DHF LV Pressure LV Pressure LV Pressure LV Pressure LA Pressure LA Pressure LA Pressure E A E A E LA Pressure A E A PVs PVd IVRT PVs PVd DT PVs PVd PVs PVd PVa PVa PVa PVa Time Time Time Time

Outline Background on Diastolic Dysfunction & Diastolic Heart Failure. Review of Parameters used for evaluation of Diastolic Dysfunction & Diastolic Heart Failure. Morphological Parameters Functional Parameters o Transmitral flow o Pulmonary Vein flow o Myocardial tissue velocity imaging Definition What are the factors that affect it? How is it different than other functional parameters? How is it measured using Echo and CMR? What is the clinical utility of this parameter? Is there data to show its clinical value?

Outline Background on Diastolic Dysfunction & Diastolic Heart Failure. Review of Parameters used for evaluation of Diastolic Dysfunction & Diastolic Heart Failure. Morphological Parameters Functional Parameters o Transmitral flow o Pulmonary Vein flow o Myocardial tissue velocity imaging Definition What are the factors that affect it? How is it different than other functional parameters? How is it measured using Echo and CMR? What is the clinical utility of this parameter? Is there data to show its clinical value?

Functional Parameter # 3: Myocardial Tissue Motion Definition: It is the velocity of the myocardial tissue during systole and diastole expressed in cm/ sec. Myocardial motion NOT blood pool. It can be conveniently divided into: o Motion during systole o Motion during diastole

Factors affecting myocardial tissue velocity Systolic myocardial velocity depends on: Contractility Diastolic myocardial Velocity depends on Myocardial relaxation Is independent of LV filling pressure

Myocardial Velocity Vs. Trans-mitral flow Myocardial Velocity Early diastole o LV relaxation Late Diastole o LV relaxation & o LV distention due to LA contraction Transmitral Blood Vel Early Filling (E wave) o LA-LV pressure Gradient o LV relaxation o LV stiffness o Mitral Valve inertness Late Filling (A wave) o LV stiffness o LA contractility

Need for this parameter? Non-invasive Is not a dynamic parameter like TMF; depends predominantly on LV relaxation. In conjunction with TMF can be used to estimate the LV pressure gradient.

Factors affecting myocardial tissue velocity in health and disease Adapted from Paelinck BP et al, A, JACC 45(7), 2005

Normal Diastolic Function

Grade 3 Diastolic Heart Failure

Outline Background on Diastolic Dysfunction & Diastolic Heart Failure. Review of Parameters used for evaluation of Diastolic Dysfunction & Diastolic Heart Failure. Morphological Parameters Functional Parameters o Transmitral flow o Pulmonary Vein flow o Myocardial tissue velocity imaging Definition What are the factors that affect it? How is it different than other functional parameters? How is it measured using Echo and CMR? What is the clinical utility of this parameter? Is there data to show its clinical value?

Tissue Doppler Imaging SYSTOLE DIASTOLE E A

M Transmitral Flow

Myocardial Tissue Velocity

Outline Background on Diastolic Dysfunction & Diastolic Heart Failure. Review of Parameters used for evaluation of Diastolic Dysfunction & Diastolic Heart Failure. Morphological Parameters Functional Parameters o Transmitral flow o Pulmonary Vein flow o Myocardial tissue velocity imaging Definition What are the factors that affect it? How is it different than other functional parameters? How is it measured using Echo and CMR? What is the clinical utility of this parameter? Is there data to show its clinical value?

Grading Adapted from Journal of American Society of Echocardiography Feb 2009-Recommendations for the evaluation of left ventricular diastolic dysfunction by echocardiography Grade 0 Normal ABNORMAL Grade I Grade 2 Grade 3

Clinical Utility of Myocardial Tissue Velocity Imaging in diastolic Dysfunction

Clinical Utility of Myocardial Tissue Velocity Imaging Mitral Valve Flow E Tissue Doppler Imaging A PSEUDONORMAL

Clinical Utility of Myocardial Tissue Velocity Imaging Transmitral Flow Myocardial Tissue Velocity PSEUDONORMAL

Outline Background on Diastolic Dysfunction & Diastolic Heart Failure. Review of Parameters used for evaluation of Diastolic Dysfunction & Diastolic Heart Failure. Morphological Parameters Functional Parameters o Transmitral flow o Pulmonary Vein flow o Myocardial tissue velocity imaging Definition What are the factors that affect it? How is it different than other functional parameters? How is it measured using Echo and CMR? What is the clinical utility of this parameter? Is there data to show its clinical value?

Clinical Validity of Myocardial Tissue Velocity Imaging

Future Directions Further large validation studies are needed. Clinical studies in different patient subsets is needed. What is a true imaging gold Std? Role of Radial Myocardial velocities?

Thank you for your attention...